Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2007-04-13 | Dr. Esteban Cvitkovic became a director in February 2007. ... The table below represents the compensation paid to our directors during the year ended December 31, 2006: Esteban Cvitkovic, MD: Fees earned or Paid in Cash ($) -, Option Awards ($) -, Total ($) -. |
| 2008-04-22 | Dr. Esteban Cvitkovic became a director in February 2007 as Vice Chairman (Europe) ... Director Compensation Table - 2007: Esteban Cvitkovic total compensation $420,000. |
| 2009-04-22 | Dr. Esteban Cvitkovic has served as a Director and consultant. ... Dr. Cvitkovic received $350,000 for scientific consulting services in 2008. ... The table below represents the compensation paid to our outside directors during the year ended December 31, 2008: ... Esteban Cvitkovic, MD (4) Fees earned or Paid in Cash ($) 12,000 Option Awards ($)(1) 180,000 All Other Compensation ($) 350,000 Total ($) 542,000. |
| 2010-04-16 | Esteban Cvitkovic, MD (4) - Represents expense recognized in 2009 in respect of options to purchase 100,000 shares of our Common Stock based on a grant date fair value of $115,000. Includes $132,000 Dr. Cvitkovic received for scientific consulting services in 2009. Dr. Cvitkovic has options to purchase 156,000 shares of our Common Stock and warrants to purchase 200,000 of our Common Stock at December 31, 2009. |
| 2011-04-14 | Esteban Cvitkovic, MD, 61, Vice Chairman – Europe; Represents expense recognized in 2010 in respect of options to purchase 25,000 shares of our common stock based on a grant date fair value of $53,000. Includes $132,000 Dr. Cvitkovic received for scientific consulting services in 2010. |
| 2012-04-16 | Dr. Esteban Cvitkovic, a Director, has served as a consultant and Senior Director, Oncology Clinical Research & Development, since August 2007. Dr. Cvitkovic receives payments for consulting expenses and reimbursement of direct expenses. In March 2011, Dr. Cvitkovic also received 35,000 shares of our common stock valued at $71,000 for his consulting. Dr. Cvitkovic’s payments for consulting services and expense reimbursements are as follows: Consulting Fees $139,000, Expense Reimbursement $14,000, Stock $71,000, Total $264,000. |
Data sourced from SEC filings. Last updated: 2025-08-30